These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 4607666

  • 41. Catecholamines in the brain as mediators of amphetamine psychosis.
    Snyder SH.
    Arch Gen Psychiatry; 1972 Aug; 27(2):169-79. PubMed ID: 4339577
    [No Abstract] [Full Text] [Related]

  • 42. Uptake of 5-hydroxytryptamine and 5-hydroxytryptophan by neurons of the central nervous system normally containing catecholamines.
    Lichtensteiger W, Mutzner U, Langemann H.
    J Neurochem; 1967 May; 14(5):489-97. PubMed ID: 5297947
    [No Abstract] [Full Text] [Related]

  • 43. Pharmacology of the brain.
    Valdman AV.
    Nurs Mirror Midwives J; 1967 Apr 28; 124(4):1-92. PubMed ID: 5336687
    [No Abstract] [Full Text] [Related]

  • 44. Tolerance to LSD and DOB induced shaking behaviour: differential adaptations of frontocortical 5-HT(2A) and glutamate receptor binding sites.
    Buchborn T, Schröder H, Dieterich DC, Grecksch G, Höllt V.
    Behav Brain Res; 2015 Mar 15; 281():62-8. PubMed ID: 25513973
    [Abstract] [Full Text] [Related]

  • 45. [Lysergic acid diethylamide blockade of the brain serotoninergic receptors prevents the facilitating effect of phenamine on self-stimulation in rats with destruction of the medial prefrontal cortex].
    Shabanov PD, Lebedev AA.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1994 Mar 15; 44(6):1124-9. PubMed ID: 7879436
    [Abstract] [Full Text] [Related]

  • 46. Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.
    Marona-Lewicka D, Thisted RA, Nichols DE.
    Psychopharmacology (Berl); 2005 Jul 15; 180(3):427-35. PubMed ID: 15723230
    [Abstract] [Full Text] [Related]

  • 47. Effects of a haloalkylamine on responses to and disposition of sympathomimetic amines.
    Kalsner S, Nickerson M.
    Br J Pharmacol; 1969 Mar 15; 35(3):440-55. PubMed ID: 5809736
    [Abstract] [Full Text] [Related]

  • 48. Pharmacological characterization of 3H-LSD binding sites in mouse brain in vivo.
    Duchemin AM, Quach TT, Rose C, Schwartz JC.
    Life Sci; 1979 Jan 29; 24(5):401-9. PubMed ID: 431327
    [No Abstract] [Full Text] [Related]

  • 49. Stereotyped and non-stereotyped behaviour in rats induced by various stimulant drugs.
    Fog R.
    Psychopharmacologia; 1969 Jan 29; 14(4):299-304. PubMed ID: 4390790
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. FACTORS MODIFYING CHLORPROMAZINE HYPERTHERMIA IN YOUNG ALBINO MICE.
    BAGDON WJ, MANN DE.
    J Pharm Sci; 1965 Feb 29; 54():240-6. PubMed ID: 14293811
    [No Abstract] [Full Text] [Related]

  • 55. [Role of the lungs in the inactivation of serotonin].
    Dubileĭ PV, Urazaeva ZV.
    Biull Eksp Biol Med; 1974 Aug 29; 78(8):16-9. PubMed ID: 4433750
    [No Abstract] [Full Text] [Related]

  • 56. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD, Sanders-Bush E.
    Mol Pharmacol; 1992 Nov 29; 42(5):826-30. PubMed ID: 1359397
    [Abstract] [Full Text] [Related]

  • 57. The effects of some drugs on the electrical activity of the brain.
    BRADLEY PB, ELKES J.
    Brain; 1957 Mar 29; 80(1):77-117. PubMed ID: 13412997
    [No Abstract] [Full Text] [Related]

  • 58. Effect upon the analgesic action of reserpine of central nervous system stimulants and drugs affecting the metabolism of catechol- and indole-amines.
    LEME JG, ROCHA E SILVA M.
    J Pharm Pharmacol; 1963 Jul 29; 15():454-60. PubMed ID: 13929554
    [No Abstract] [Full Text] [Related]

  • 59. Involvement of brain serotonin in the stimulant action of amphetamine and of cholinolytics.
    Lapin IP, Oxenkrug GF, Azbekyan SG.
    Arch Int Pharmacodyn Ther; 1972 Jun 29; 197(2):350-61. PubMed ID: 4260601
    [No Abstract] [Full Text] [Related]

  • 60. Recognition and activation mechanisms on the LSD/serotonin receptor: the molecular basis of structure activity relationships.
    Weinstein H, Green JP, Osman R, Edwards WD.
    NIDA Res Monogr; 1978 Jun 29; (22):333-58. PubMed ID: 101884
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.